je.st
news
Tag: merck
11.21% Advantage To 5 Dow Highest Yield, Lowest Price, April Dogs With Merck
2015-04-05 22:07:26| IT Services - Topix.net
Top ten Dow Industrial dividend stocks by yield showed 11.21% higher net gain from a $5k investment in the lowest priced five than from the same investment in all ten. Annual dividends estimated by Yahoo.com divided by closing stock prices as of April 2 determined yields.
Tags: with
price
april
highest
Merck scholarship program recognizes 34 vet students
2015-03-31 15:22:55| Beef
Thirty-four veterinary students from not just the U.S. but around the world now have the resources to enter the veterinary profession with a little less debt. Merck Animal Health announces the recipients of the Merck Animal Health Veterinary Student Scholarship Program, awarding $170,000 in scholarships through a partnership with the American Veterinary Medical Foundation (AVMF). The program recognizes outstanding second- and third-year students who are pursuing careers in large animal and companion animal medicine. read more
Tags: program
students
vet
recognizes
Syndax and Merck to Collaborate on Immuno-Oncology Study Evaluating Entinostat in Combination with KEYTRUDA (pembrolizumab) in Lung Cancer and Melanoma
2015-03-31 14:00:00| Merck.com - Product News
Dateline City: WALTHAM, Mass. & KENILWORTH, N.J. WALTHAM, Mass. & KENILWORTH, N.J.--(BUSINESS WIRE)--Syndax Pharmaceuticals, Inc., and Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that they have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining Syndaxs entinostat, an investigational epigenetic therapy, with Mercks KEYTRUDA (pembrolizumab), the first anti-PD-1 therapy approved in the United States. Language: English Contact: Merck Media Relations:Pamela Eisele, 267-305-3558Claire Mulhearn, 908-236-1118orMerck Investor Relations:Justin Holko, 908-740-1879orSyndax Corporate:Bob Goodenow, 781-419-1418Chief Business Officerbgoodenow@syndax.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
combination
cancer
evaluating
Merck to Hold First-Quarter 2015 Sales and Earnings Conference Call on April 28
2015-03-27 13:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its first-quarter 2015 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, April 28. During the call, company executives will provide an overview of Mercks performance for the quarter. Language: English Contact: MerckMedia:Lainie Keller, (908) 236-5036Steven Cragle, (908) 740-1801orInvestor:Justin Holko, (908) 740-1879Joe Romanelli, (908) 740-1986 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck Announces New $10 Billion Share Repurchase Program
2015-03-24 22:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that its board of directors has authorized additional purchases of up to $10 billion of Mercks common stock for its treasury. The treasury stock purchase has no time limit and will be made over time in open-market transactions, block transactions on or off an exchange, or in privately negotiated transactions. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036or Steve Cragle, 908-740-1801orInvestor:Joseph Romanelli, 908-740-1986or Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: program
share
billion
announces
Sites : [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] next »